Capital Analysts »

Avita Therapeutics shares owned by Capital Analysts

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Capital Analysts from 13F filings

Historical chart of Capital Analysts investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Capital Analysts

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.0k 652 13.80
2023-09-30 $10k 652 15.34
2023-06-30 $11k 652 16.87
2023-03-31 $9.0k 652 13.80
2022-12-31 $4.0k 652 6.14
2022-09-30 $3.0k 652 4.60
2022-06-30 $3.0k 652 4.60
2022-03-31 $6.0k 652 9.20
2021-12-31 $8.0k 652 12.27
2021-09-30 $12k 652 18.40
2021-06-30 $13k 652 19.94
2021-03-31 $13k 652 19.94